Abstract
PURPOSE: This study investigates the clinical outcomes of various bone grafting materials used in maxillofacial reconstruction, focusing on their effectiveness, biocompatibility, and complications. MATERIALS AND METHODS: A prospective cohort of 150 patients undergoing maxillofacial reconstruction was analyzed. The cohort was divided based on the use of autogenous, allograft, and synthetic materials. Postoperative outcomes were measured over six months. RESULTS: Autogenous grafts exhibited the highest graft integration rates (95%) but were associated with increased donor-site morbidity. Allografts had moderate success (85%) with minimal complications. Synthetic materials demonstrated the lowest integration rates (75%) but had the advantage of unlimited supply and reduced complications. CONCLUSION: Each material offers unique benefits, with selection tailored to clinical needs. Autogenous grafts remain the gold standard, while synthetic materials provide a viable alternative for specific indications.